Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) HKSE

3.24

-0.14(-4.14%)

Updated at October 17 04:08PM

Currency In HKD

Valuation

Market Cap2.39B
Enterprise Value1.36B
P/E Ratio-370.37
PEG Ratio2.28
Price/Sales Ratio1.5
Price/Book Ratio4.07
Enterprise/Revenue-0.09
Enterprise/EBITDA-3.95

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.04
Operating Margin-0.08

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.01

Income Statement

Revenue709.4M
Revenue/Share0.66
Gross Profit648.19M
EBITDA48.09M
Net Income39.73M
Diluted EPS0.04

Balance Sheet

Total Cash1.11B
Total Cash/Share1.07
Total Debt17.26M
Total Debt/Equity0.01
Current Ratio6.96
Book Value Per Share2.2

Price History

52-Week Change10.2
52-Week High5.29
52-Week Low2.13
Moving Average 50 Days3.69
Moving Average 200 Days3.06

Statistics

Average Volume11.4M
Shares Outstanding340M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield0.56
Payout Ratio-7.37
Last Split FactorN/A
Last Split DateN/A